Protagonist Therapeutics PTGX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's quick ratio?
- Protagonist Therapeutics (PTGX) reported quick ratio of 17.8× in Q1 2026.
- How has Protagonist Therapeutics's quick ratio changed year-over-year?
- Protagonist Therapeutics's quick ratio increased by 2.9% year-over-year, from 17.3× to 17.8×.
- What is the long-term trend for Protagonist Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's quick ratio has grown at a 10.1% compound annual growth rate (CAGR), from 7.8× to 12.7×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.